Pharmacokinetics of a 900 mg Oral Formulation of Delafloxacin in Healthy Subjects Supporting a Gonorrhea Phase 3 Study.
Phase of Trial: Phase I
Latest Information Update: 16 Sep 2014
At a glance
- Drugs Delafloxacin (Primary)
- Indications Gonorrhoea
- Focus Pharmacokinetics
- Sponsors Melinta Therapeutics
- 16 Sep 2014 New trial record
- 09 Sep 2014 Results presented at the 54th Interscience Conference on Antimicrobial Agents and Chemotherapy.
- 06 Sep 2014 Results published in the Media Release.